Science to Improve Life
With clinical trial experience since 2003, Ivy Life Sciences has developed safe and effective cancer treatments. Our technologies can improve the overall survival, prolong disease-free survival, and patients' quality of life.
Our Story
According to MOHW figures in 2019, cancer has been the leading cause of death in Taiwan for 38 years. In order to confront this societal problem, Ivy Life Sciences has dedicated itself to the treatment of cancer since 2003. Establishing state of the art cell culture laboratories and producing innovative cell therapies, we stand on the side of cancer patients on their fight against cancer.
Mission Statement
【Using Science to Improve Life】
With the strictest standards, Ivy Life Sciences continues to develop cell therapy technology and provide more treatment methods to patients.
Immune Cell Banking
Banking of immune cells has many applications in the future. Currently it is already recognized internationally cancer treatment. Emerging evidence suggests other applications can included but not limited to, treating infectious diseases.
The Ivy Advantage
CIK immune cell therapy Ivy's market share exceeds 50%
Patented Immune Killer Cell (IKC®) technology
The Only Cell Processing Center with Partner Medical Centers in North, Central and South Taiwan
Pioneer of Immune Cell Therapy and First-in-Human Clinical Trials Since 2003
1st in Taiwan to obtain "Cell Processing Center" License" issued by the Ministry of Health and Welfare
Immune Cell Therapy experience since 2003, Your First Choice for Immune Cell Therapy
Back to top